Insmed annual operating margin
2009
2010
2011
2013
2018
2019
2020
2021
2022
2023
2024
2025
Insmed's operating margin was −205.59% for fiscal 2025.
View full Insmed company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −205.59% | +35.88 pp |
| 2024 | 2024-12-31 | −241.47% | −8.97 pp |
| 2023 | 2023-12-31 | −232.51% | −46.12 pp |
| 2022 | 2022-12-31 | −186.39% | +12.64 pp |
| 2021 | 2021-12-31 | −199.03% | −37.71 pp |
| 2020 | 2020-12-31 | −161.32% | +11.06 pp |
| 2019 | 2019-12-31 | −172.38% | +2952.56 pp |
| 2018 | 2018-12-31 | −3,124.94% | −2646.55 pp |
| 2013 | 2013-12-31 | −478.39% | +918.91 pp |
| 2011 | 2011-12-31 | −1,397.31% | −1280.39 pp |
| 2010 | 2010-12-31 | −116.92% | −33.30 pp |
| 2009 | 2009-12-31 | −83.62% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −0.36% | +290.91 pp |
| Q1 2026 | 2026-03-31 | −50.11% | +217.22 pp |
| Q4 2025 | 2025-12-31 | −121.19% | +99.43 pp |
| Q3 2025 | 2025-09-30 | −257.13% | −28.68 pp |
| Q2 2025 | 2025-06-30 | −291.28% | +28.52 pp |
| Q1 2025 | 2025-03-31 | −267.33% | −74.60 pp |
| Q4 2024 | 2024-12-31 | −220.61% | −7.61 pp |
| Q3 2024 | 2024-09-30 | −228.45% | −41.70 pp |
| Q2 2024 | 2024-06-30 | −319.80% | −14.82 pp |
| Q1 2024 | 2024-03-31 | −192.72% | +34.47 pp |
| Q4 2023 | 2023-12-31 | −213.01% | +42.43 pp |
| Q3 2023 | 2023-09-30 | −186.75% | +1.79 pp |
| Q2 2023 | 2023-06-30 | −304.97% | −169.56 pp |
| Q1 2023 | 2023-03-31 | −227.19% | −58.03 pp |
| Q4 2022 | 2022-12-31 | −255.44% | −78.90 pp |
| Q3 2022 | 2022-09-30 | −188.54% | +33.07 pp |
| Q2 2022 | 2022-06-30 | −135.41% | +59.82 pp |
| Q1 2022 | 2022-03-31 | −169.15% | +39.31 pp |
| Q4 2021 | 2021-12-31 | −176.53% | +51.74 pp |
| Q3 2021 | 2021-09-30 | −221.61% | −92.78 pp |
| Q2 2021 | 2021-06-30 | −195.23% | −67.88 pp |
| Q1 2021 | 2021-03-31 | −208.47% | −44.72 pp |
| Q4 2020 | 2020-12-31 | −228.27% | −125.26 pp |
| Q3 2020 | 2020-09-30 | −128.82% | +16.44 pp |
| Q2 2020 | 2020-06-30 | −127.34% | +80.07 pp |
| Q1 2020 | 2020-03-31 | −163.75% | +153.62 pp |
| Q4 2019 | 2019-12-31 | −103.01% | +788.93 pp |
| Q3 2019 | 2019-09-30 | −145.27% | −73.37 pp |
| Q2 2019 | 2019-06-30 | −207.41% | +424.87 pp |
| Q1 2019 | 2019-03-31 | −317.36% | +7719.42 pp |
| Q4 2018 | 2018-12-31 | −891.94% | +178.92 pp |
| Q2 2013 | 2013-06-30 | −71.90% | +391.24 pp |
| Q4 2011 | 2011-12-31 | −632.29% | −599.19 pp |
| Q3 2011 | 2011-09-30 | −8,036.78% | −7987.80 pp |
| Q2 2011 | 2011-06-30 | −1,070.86% | — |
| Q1 2011 | 2011-03-31 | −463.15% | — |
| Q3 2010 | 2010-09-30 | −33.09% | — |
| Q2 2010 | 2010-06-30 | −48.98% | — |
Over the last five reported fiscal years, Insmed's operating margin decreased from −161.32% to −205.59%, a change of −44.27 percentage points. The latest reported quarter, Q2 2026, shows −0.36%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Insmed filings at SEC.gov ↗